Nowadays, the population is rapidly ageing because of increasing life expectancy and decreasing birth rates. Thus, the purpose of this systematic review is to prepare a comprehensive overview which identifies the activities of daily living (ADLs) that are gradually reduced among patients with dementia, as well as explore the therapies applied in relation to dementia and how they effectively improve the quality of life (QoL) of patients and caregivers. Furthermore, we aim to summarise the ADL activities influenced by therapies and examine the treatment costs and care for patients so that recommendations for research and development (R&D) can be made to improve both the QoL of people with dementia and cost-saving measures. The research focuses on four selected neurodegenerative diseases: Alzheimer, Parkinson, vascular dementia, and amyotrophic lateral sclerosis. Therefore, the peer-reviewed English written articles from 2014 to 2019 were searched between September 1 and December 13, 2019. Twenty-seven papers were included in the analysis. The results show that essential assistance occurs in connection with activities: eating, drinking, dressing, bathing, personal hygiene, use of the toilet, and transport. By contrast, shopping or cleaning is not addressed as much. A lower ability to take care of oneself is connected with poor patient health and higher social care costs because the patient requires care from external sources, such as home aid or nurse visits. The challenge that remains is to shift new knowledge from scientific disciplines and connect it with the needs of patients to remove legitimate barriers and increase the acceptance of new solutions by popularisation. Additionally, regarding the burden on caregivers, it would be appropriate to promote this area of education and employment so that family members can use formal caregivers, ensuring them free time and much-needed rest.

Center for Basic and Applied Science Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove 500 03 Czech Republic

Department of Applied Linguistics Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove 500 03 Czech Republic

Department of Economics Faculty of Informatics and Management University of Hradec Kralove Hradec Kralove 500 03 Czech Republic

Faculty of Transport and Communications University of Sarajevo Sarajevo 71000 Bosnia and Herzegovina

Zobrazit více v PubMed

WHO. 10 facts on ageing and health. WHO. Available from: http://www.who.int/features/factfiles/ageing/en/. Accessed July26, 2020.

World Population Ageing. 2017. Available from: https://www.un.org/en/development/desa/population/theme/ageing/WPA2017.asp. Accessed July26, 2020.

Klimova B, Kuca K. Speech and language impairments in dementia. DOI

Kuca K, Maresova P, Klimova B, Valis M, Hort J. Alzheimer’s disease and language impairments: social intervention and medical treatment. PubMed DOI PMC

Maresova P, Klimova B, Novotny M, Kuca K. Alzheimer’s and parkinson’s diseases: expected economic impact on Europe—a call for a uniform European strategy. PubMed DOI

Klimova B, Toman J, Kuca K. Effectiveness of the dog therapy for patients with dementia - a systematic review. PubMed DOI PMC

Caregiving for Person with Alzheimer’s Disease or a related Dementia. Alzheimer’s disease and healthy aging. CDC. December 19, 2019. Available from: https://www.cdc.gov/aging/caregiving/alzheimer.htm. Accessed March7, 2020

WHO. Key facts. Key facts. 2019. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed March7, 2020.

Baraković S, Baraković Husić J, van Hoof J, et al. Quality of life framework for personalised ageing: a systematic review of ICT solutions. PubMed DOI PMC

Bovolenta TM, de Azevedo Silva SMC, Arb Saba R, Borges V, Ferraz HB, Felicio AC. Systematic review and critical analysis of cost studies associated with parkinson’s disease. PubMed DOI PMC

El-Hayek YH, Wiley RE, Khoury CP, et al. Tip of the iceberg: assessing the global socioeconomic costs of alzheimer’s disease and related dementias and strategic implications for stakeholders. PubMed DOI PMC

Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: a summary report and call to action: burden of neurological disease. PubMed DOI

Jutten RJ, Dicks E, Vermaat L, et al. Impairment in complex activities of daily living is related to neurodegeneration in alzheimer’s disease–specific regions. PubMed DOI

Ritchie K, Lovestone S. The dementias. PubMed DOI

Novotny M, Klimova B, Valis M. Nitrendipine and Dementia: forgotten positive facts? PubMed DOI PMC

Yoshida M. Amyotrophic lateral sclerosis with dementia: the clinicopathological spectrum. PubMed DOI

Cummings JL. Alzheimer’s disease. Wood AJJ, ed. PubMed DOI

Aarsland D, Andersen K, Larsen JP, Lolk A. Prevalence and characteristics of dementia in parkinson disease: an 8-year prospective study. PubMed DOI

Burn DJ, McKeith IG. Current treatment of dementia with Lewy bodies and dementia associated with parkinson’s disease. PubMed DOI

Janvin CC, Larsen JP, Salmon DP, Galasko D, Hugdahl K, Aarsland D. Cognitive profiles of individual patients with parkinson’s disease and dementia: comparison with dementia with lewy bodies and alzheimer’s disease: cognition in parkinson’s disease with dementia. PubMed DOI

Boller F.

Joling KJ, Schöpe J, van Hout HPJ, van Marwijk HWJ, van der Horst HE, Bosmans JE. Predictors of societal costs in dementia patients and their informal caregivers: a two-year prospective cohort study. PubMed DOI

Clark PG. Quality of life, values, and teamwork in geriatric care: do we communicate what we mean? PubMed DOI

van Hoof J, Beneken Genaamd Kolmer DM, de Vlugt E, de Vries SI. Quality of life: the interplay between human behaviour, technology and the environment. PubMed DOI PMC

Post M. Definitions of quality of life: what has happened and how to move on. PubMed DOI PMC

Hörnquist JO. The concept of quality of life. PubMed DOI

Marston H. “Who doesn’t think about technology when designing urban environments for older people?” A case study approach to a proposed extension of the WHO’s age-friendly cities model. PubMed DOI PMC

van Hoof J, Kazak J, Perek-Białas J, Peek S. The challenges of urban ageing: making cities age-friendly in Europe. PubMed DOI PMC

Rajati F, Ashtarian H, Salari N, Ghanbari M, Naghibifar Z, Hosseini S. Quality of life predictors in physically disabled people. PubMed DOI PMC

Davidson G, Irvine R, Corman M, et al. Measuring the quality of life of people with disabilities and their families.:101.

Maresova P, Krejcar O, Barakovic S, et al. Health–related ICT solutions of smart environments for elderly–systematic review. DOI

Ettema TP, Dröes R-M, de Lange J, Mellenbergh GJ, Ribbe MW. A review of quality of life instruments used in dementia. PubMed DOI

Chua K-C, Brown A, Little R, et al. Quality-of-life assessment in dementia: the use of DEMQOL and DEMQOL-proxy total scores. PubMed DOI PMC

Hendriks AAJ, Smith SC, Black N. DEMQOL and DEMQOL-proxy: a rasch analysis among those diagnosed with dementia. PubMed DOI PMC

Chua K-C, Böhnke JR, Prince M, Banerjee S. Health-related quality-of-life assessment in dementia: evidence of cross-cultural validity in Latin America. PubMed DOI PMC

Woods B, O’Philbin L, Farrell EM, Spector AE, Orrell M. Reminiscence therapy for dementia. Cochrane dementia and cognitive improvement Group, ed. PubMed DOI PMC

Harris MA. The relationship between physical inactivity and mental wellbeing: findings from a gamification-based community-wide physical activity intervention. PubMed DOI PMC

Abraha I, Rimland JM, Trotta FM, et al. Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series. PubMed DOI PMC

Shlisky J, Bloom DE, Beaudreault AR, et al. Nutritional considerations for healthy aging and reduction in age-related chronic disease. PubMed DOI PMC

Shaji KS, Sivakumar PT, Rao GP, Paul N. Clinical practice guidelines for management of dementia. PubMed DOI PMC

Briggs R, Kennelly SP, O’Neill D. Drug treatments in alzheimer’s disease. PubMed DOI PMC

Frankenstein LL, Jahn G. Behavioral and occupational therapy for dementia patients and caregivers. DOI

Gibbor L, Yates L, Volkmer A, Spector A. Cognitive stimulation therapy (CST) for dementia: a systematic review of qualitative research. PubMed DOI

Orrell M, Yates LA, Burns A, et al. Individual Cognitive Stimulation Therapy for dementia (iCST): study protocol for a randomized controlled trial. PubMed DOI PMC

Ali A, Brown E, Spector A, Aguirre E, Hassiotis A. Individual cognitive stimulation therapy for people with intellectual disability and dementia: protocol of a feasibility randomised controlled trial. PubMed DOI PMC

Clemmensen TH, Lauridsen HH, Andersen‐Ranberg K, Kristensen HK. “I know his needs better than my own” – carers’ support needs when caring for a person with dementia. PubMed DOI PMC

Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PubMed DOI PMC

Leung XY, Sun J, Bai B. Bibliometrics of social media research: a co-citation and co-word analysis. DOI

Arksey H, O’Malley L. Scoping studies: towards a methodological framework. DOI

Alzheimer Europe - policy - national dementia strategies. Available from: https://www.alzheimer-europe.org/Policy/National-Dementia-Strategies. Accessed May6, 2020.

Jennings LA, Laffan AM, Schlissel AC, et al. Health care utilization and cost outcomes of a comprehensive dementia care program for medicare beneficiaries. PubMed DOI PMC

Zwicker J, Qureshi D, Talarico R, et al. Dying of amyotrophic lateral sclerosis: health care use and cost in the last year of life. PubMed DOI

Sopina E, Spackman E, Martikainen J, Waldemar G, Sørensen J. Long-term medical costs of alzheimer’s disease: matched cohort analysis. PubMed DOI

Pyenson B, Sawhney TG, Steffens C, et al. The real-world medicare costs of alzheimer disease: considerations for policy and care. PubMed DOI PMC

Takechi H, Kokuryu A, Kuzuya A, Matsunaga S. Increase in direct social care costs of alzheimer’s disease in Japan depending on dementia severity. PubMed DOI

Jönsson L, Jönhagen ME, Kilander L, et al. Determinants of costs of care for patients with alzheimer’s disease. PubMed DOI

Leicht H, Heinrich S, Heider D, et al. Net costs of dementia by disease stage: net costs of dementia by disease stage. PubMed DOI

Gustavsson A, Brinck P, Bergvall N, et al. Predictors of costs of care in alzheimer’s disease: a multinational sample of 1222 patients. PubMed DOI

Reese JP, Heßmann P, Seeberg G, et al. Cost and care of patients with alzheimer’s disease: clinical predictors in german health care settings. PubMed DOI

Gustavsson A, Cattelin F, Jönsson L. Costs of care in a mild-to-moderate alzheimer clinical trial sample: key resources and their determinants. PubMed DOI

Tamás G, Gulácsi L, Bereczki D, et al. Quality of life and costs in parkinson’s disease: a cross sectional study in Hungary. Chen R, ed. PubMed DOI PMC

Brüggenjürgen B, Andersohn F, Ezzat N, Lacey L, Willich S. Medical management, costs, and consequences of alzheimer’s disease in Germany: an analysis of health claims data. PubMed DOI

Jones RW, Lebrec J, Kahle-Wrobleski K, et al. Disease progression in mild dementia due to alzheimer disease in an 18-month observational study (GERAS): the impact on costs and caregiver outcomes. PubMed DOI PMC

Reed C, Belger M, Vellas B, et al. Identifying factors of activities of daily living important for cost and caregiver outcomes in alzheimer’s disease. PubMed DOI

Weir S, Samnaliev M, Kuo T-C, et al. Short- and long-term cost and utilization of health care resources in parkinson’s disease in the UK: costs of treating PD in UK. PubMed DOI

Belger M, Haro JM, Reed C, et al. Determinants of time to institutionalisation and related healthcare and societal costs in a community-based cohort of patients with alzheimer’s disease dementia. PubMed DOI PMC

Giebel CM, Sutcliffe C, Challis D. Activities of daily living and quality of life across different stages of dementia: a UK study. PubMed DOI

Duru Aşiret G, Kapucu S. The effect of reminiscence therapy on cognition, depression, and activities of daily living for patients with alzheimer disease. PubMed DOI

Lima-Silva TB, Bahia VS, Carvalho VA, et al. Direct and indirect assessments of activities of daily living in behavioral variant frontotemporal dementia and alzheimer disease. PubMed DOI

Barbe C, Morrone I, Wolak-Thierry A, et al. Impact of functional alterations on quality of life in patients with alzheimer’s disease. PubMed DOI

Puente AN, Cohen ML, Aita S, Brandt J. Behavioral ratings of executive functioning explain instrumental activities of daily living beyond test scores in parkinson’s disease. PubMed DOI

Giebel CM, Burns A, Challis D. Taking a positive spin: preserved initiative and performance of everyday activities across mild alzheimer’s, vascular and mixed dementia: preserved everyday activities across dementia subtypes. PubMed DOI

Hagell P. Measuring activities of daily living in Parkinson’s disease: on a road to nowhere and back again? DOI

Gorecka-Mazur A, Furgala A, Krygowska-Wajs A, Pietraszko W, Kwinta B, Gil K. Activities of daily living and their relationship to health-related quality of life in patients with parkinson disease after subthalamic nucleus deep brain stimulation. PubMed DOI

Lopez FV, Ferencz B, Rohl BY, et al. Everyday functioning in parkinson’s disease: evidence from the revised-Observed Tasks of Daily Living (OTDL-R). PubMed DOI PMC

Shepard DS. Cost-effectiveness in health and medicine. By M.R. Gold, J.E Siegel, L.B. Russell, and M.C. Weinstein (eds). New York: oxford University Press, 1996. DOI

Jönsson B. Ten arguments for a societal perspective in the economic evaluation of medical innovations. PubMed DOI

Evers SMAA, Hiligsmann M, Adarkwah CC. Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies. PubMed DOI

Drost RMWA, van der Putten IM, Ruwaard D, Evers SMAA, Paulus ATG. Conceptualizations of the societal perspective within economic evaluations: a systematic review. PubMed DOI

Sturkenboom IHWM, Hendriks JCM, Graff MJL, et al. Economic evaluation of occupational therapy in parkinson’s disease: a randomized controlled trial: economic evaluation OTIP study. PubMed DOI

Hwang AS, Truong KN, Cameron JI, Lindqvist E, Nygård L, Mihailidis A. Co-Designing Ambient Assisted Living (AAL) environments: unravelling the situated context of informal dementia care. PubMed DOI PMC

Lotfi A, Langensiepen C, Mahmoud SM, Akhlaghinia MJ. Smart homes for the elderly dementia sufferers: identification and prediction of abnormal behaviour. DOI

Lyons BE, Austin D, Seelye A, et al. Pervasive computing technologies to continuously assess alzheimer†PubMed DOI PMC

Zdravevski E, Lameski P, Trajkovik V, et al. Improving activity recognition accuracy in ambient-assisted living systems by automated feature engineering. DOI

Coduras A, Rabasa I, Frank A, et al. Prospective one-year cost-of-illness study in a cohort of patients with dementia of alzheimer’s disease type in Spain: the ECO study. PubMed DOI